The Ethics Decision-Making tool uses questions and games to help the viewer improve their understanding of ethics and how to respond to situations that fall into a gray area. One question about a hypothetical decision: 'Would it be okay to see it on the front page of a newspaper?’ How about on a blog? Either way, that's a good test. Ethics Dilemma uses a questionnaire to show how differing views of ethics can influence decisions and lead to different outcomes (look here).
"Sometimes you find yourself in a ‘grey zone’ where there is no obvious right or wrong. The new tools aim at supporting you in navigating in such a grey zone by providing a better understanding of basic ethics and practical guidance on how to make sound decisions," Lise Kingo, a Novo Nordisk executive vp, tells InPharm. "The strength is that the tools combine academic knowledge with hands on experience from business and other practitioners.”
We wonder if Novo Nordisk ceo Lars Sorensen has taken these tests. You may recall that late last month, the Danish drugmaker pulled its diabetes product from Greece after the government instituted substantial price cuts of up to 25 percent on hundreds of medicines (see background). Why? Novo Nordisk claimed it would lose money on top of $36 million the government already owes. Sorensen reportedly wrote that "the irresponsible management of finances by the Greek government which puts both you and our company in this difficult position.”
This is a business decision, but given that Novo Nordisk is promoting this new exercise, this action begs a question - how ethical is it to pull a life-saving product used by thousands of people because their government is in financial straits?